Changes in Retinal Blood Flow in Response to an Experimental Increase in IOP in Healthy Participants as Assessed With Doppler Optical Coherence Tomography.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
07 02 2020
Historique:
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 16 4 2020
Statut: ppublish

Résumé

Blood flow autoregulation is an intrinsic mechanism of the healthy retinal vasculature to keep blood flow constant when ocular perfusion pressure (OPP) is changed. In the present study, we set out to investigate retinal blood flow in response to an experimental decrease in OPP in healthy participants using Doppler optical coherence tomography. Fifteen healthy participants aged between 22 and 31 years (mean, 27 ± 3 years) were included in the present open study. IOP was increased stepwise via the suction cup method to induce a decrease in OPP. Retinal blood flow in arteries and veins was assessed using a custom-built Doppler optical coherence tomography system and pressure-flow relationships were calculated to assess autoregulation. Suction cup application induced a pronounced increase in IOP with a maximum value of 50.5 ± 8.0 mm Hg at the highest level of suction. Pressure-flow relationships revealed that blood flow was autoregulated until the OPP was decreased by approximately 21 mm Hg and started to decrease significantly when the OPP was reduced by 30 mm Hg. Retinal blood flow at the last suction period decreased at a maximum of -57.0 ± 22.3% and 65.2 ± 15.4% in retinal arteries and retinal veins, respectively. These changes in retinal blood flow were less pronounced than the decrease in OPP (-75.2 ± 19.2%), indicating retinal autoregulation. The results of the present study confirm that retinal blood flow is autoregulated in response to changes in the OPP. Doppler optical coherence tomography has the potential to become a clinical tool for the investigation of retinal blood flow autoregulation in the future, because of its ability to assess the blood velocities and diameter of the retinal vessels parallel and therefore also their blood flow in absolute values. (Clinicaltrials.gov number NCT03398616).

Identifiants

pubmed: 32084274
pii: 2761942
doi: 10.1167/iovs.61.2.33
pmc: PMC7326607
doi:

Banques de données

ClinicalTrials.gov
['NCT03398616']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Références

Invest Ophthalmol Vis Sci. 2003 Feb;44(2):734-9
pubmed: 12556406
Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):618-26
pubmed: 9349945
Exp Eye Res. 1997 May;64(5):737-44
pubmed: 9245904
Surv Ophthalmol. 2018 Sep - Oct;63(5):646-664
pubmed: 29577954
Invest Ophthalmol Vis Sci. 1997 Oct;38(11):2338-43
pubmed: 9344357
Invest Ophthalmol Vis Sci. 2012 Sep 12;53(10):6062-71
pubmed: 22893675
Invest Ophthalmol Vis Sci. 2005 May;46(5):1721-5
pubmed: 15851574
Invest Ophthalmol Vis Sci. 1986 Dec;27(12):1706-12
pubmed: 2947873
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT121-9
pubmed: 27409462
Graefes Arch Clin Exp Ophthalmol. 2004 Jan;242(1):13-7
pubmed: 14648137
Ger J Ophthalmol. 1996 Jan;5(1):1-5
pubmed: 8646172
Ophthalmologica. 2013;229(2):61-74
pubmed: 23257770
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):6035-9
pubmed: 21697134
Biomed Opt Express. 2014 Jan 28;5(2):630-42
pubmed: 24575355
Invest Ophthalmol Vis Sci. 2012 Jul 01;53(8):4337-46
pubmed: 22661477
Curr Opin Ophthalmol. 2009 Mar;20(2):73-8
pubmed: 19240538
Ophthalmic Res. 1985;17(5):308-17
pubmed: 4069567
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3768-74
pubmed: 17652750
Invest Ophthalmol Vis Sci. 2013 Mar 15;54(3):1964-70
pubmed: 23439596
Exp Eye Res. 2011 Aug;93(2):141-55
pubmed: 20868686
Invest Ophthalmol Vis Sci. 1992 Jul;33(8):2399-410
pubmed: 1634337
Exp Eye Res. 1998 Nov;67(5):561-8
pubmed: 9878218
Acta Ophthalmol. 2010 Nov;88(7):717-22
pubmed: 19681764
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):372-7
pubmed: 19124845
Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1752-60
pubmed: 9286263
Invest Ophthalmol Vis Sci. 1981 Jul;21(1 Pt 1):34-8
pubmed: 7251300
Invest Ophthalmol Vis Sci. 2014 Jan 23;55(1):485-91
pubmed: 24355824
Diabetologia. 2017 Aug;60(8):1534-1540
pubmed: 28547132
Prog Retin Eye Res. 2014 Jul;41:26-43
pubmed: 24704352
Ophthalmology. 2005 Aug;112(8):1337-42
pubmed: 16024084
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):728-33
pubmed: 12556405
Transl Vis Sci Technol. 2019 May 6;8(3):13
pubmed: 31110914
Acta Ophthalmol. 2014 Jun;92(4):e252-66
pubmed: 24238296
Surv Ophthalmol. 2007 Nov;52 Suppl 2:S134-8
pubmed: 17998038
Can J Ophthalmol. 2008 Jun;43(3):317-21
pubmed: 18493273

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH